Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomas

Fibroblast growth factor receptor 4 (FGFR4) aberrant expression and activity have been linked to the pathogenesis of a variety of cancers including rhabdomyosarcomas (RMS). We found that treatment of alveolar rhabdomyosarcoma (aRMS) cells with Guadecitabine (SGI-110), a next-generation DNA methyltra...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neoplasia
Päätekijät: Darvishi, Emad, Slemmons, Katherine, Wan, Zesheng, Mitra, Sheetal, Hou, Xiaogang, Hugues Parmentier, Jean, Eddie Loh, Yong-Hwee, Helman, Lee J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Neoplasia Press 2020
Aiheet:
Original article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7251315/
https://ncbi.nlm.nih.gov/pubmed/32464274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2020.05.001
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia